Your browser doesn't support javascript.
loading
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
Kerwin, Edward; Dorinsky, Paul; Patel, Mehul; Rossman, Kimberly; Reisner, Colin; Maes, Andrea; Darken, Patrick; Griffis, Dianne; Fjällbrant, Harald.
Afiliação
  • Kerwin E; Clinical Research Institute of Southern Oregon, Medford, OR, USA.
  • Dorinsky P; BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.
  • Patel M; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Rossman K; Formerly of BioPharmaceuticals R&D, AstraZeneca, Morristown, NJ, USA.
  • Reisner C; Formerly of BioPharmaceuticals R&D, AstraZeneca, Morristown, NJ, USA.
  • Maes A; Formerly of Biopharmaceuticals R&D, AstraZeneca, Wilmington, DE, USA.
  • Darken P; Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Griffis D; BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA.
  • Fjällbrant H; Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
J Asthma ; 59(7): 1420-1432, 2022 07.
Article em En | MEDLINE | ID: mdl-34338132

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article